• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇通过减少脂肪生成和炎症来减轻高脂喂养小鼠的肝脂肪变性。

Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.

作者信息

Andrade João Marcus Oliveira, Paraíso Alanna Fernandes, de Oliveira Marcos Vinícius Macedo, Martins Andréa Maria Eleutério, Neto João Felício, Guimarães André Luiz Sena, de Paula Alfredo Maurício, Qureshi Mahboob, Santos Sérgio Henrique Sousa

机构信息

Laboratory of Health Science, Postgraduate Program in Health Sciences, Universidade Estadual de Montes Claros, Montes Claros, Minas Gerais, Brazil.

Laboratory of Health Science, Postgraduate Program in Health Sciences, Universidade Estadual de Montes Claros, Montes Claros, Minas Gerais, Brazil; Nursing Department, Faculdades Integradas Pitágoras, Montes Claros, Minas Gerais, Brazil.

出版信息

Nutrition. 2014 Jul-Aug;30(7-8):915-9. doi: 10.1016/j.nut.2013.11.016. Epub 2013 Dec 4.

DOI:10.1016/j.nut.2013.11.016
PMID:24985011
Abstract

OBJECTIVE

Resveratrol (RSV) is the most studied natural compound that activates sirtuins, which produce beneficial metabolic effects on lipid and glucose metabolism. The aim of the present study was to investigate the role of resveratrol in preventing nonalcoholic fatty liver disease (NAFLD) and expression of liver inflammatory markers in mice treated with a high-fat diet.

METHODS AND PROCEDURES

Eighteen male mice were divided into three groups and fed for 60 d with a standard diet (ST), high-fat diet (HFD), or high-fat diet plus resveratrol (HFD + RSV, 30 mg/kg/d). Body weight, food intake, and serum total cholesterol, triacylglycerol, insulin, alanine transaminase (ALT), and aspartate aminotransferase (AST) were evaluated. Liver histology was analyzed. Expression of ACC, PPAR-γ, ChREBP, SREBP-1 c, CPT-1, tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), NF-κB, interleukin 1 β (IL-1 β), and SIRT1 were evaluated by quantitative real-time reverse transcriptase PCR (qRT-PCR).

RESULTS

The major finding of the present study was that RSV reduced body fat, total cholesterol, triacylglycerol, transaminases, and insulin plasma level. These results were accompanied with a significant reduction in TNF-α, IL-6, and NF-κB mRNA expression in the liver. Analyses of liver adipogenesis related genes indicated that ACC, PPAR-γ, and SREBP-1 mRNA expression were significantly suppressed in HFD + RSV mice. In addition, we observed increased expression of SIRT1 in the HFD + RSV group.

CONCLUSIONS

We observed that treatment with resveratrol improved lipid metabolism, and decreased NAFLD and pro-inflammatory profile in liver of mice with obesity-inducible diets. These data suggest an important clinical application of RSV in preventing liver diseases.

摘要

目的

白藜芦醇(RSV)是研究最多的激活去乙酰化酶的天然化合物,其对脂质和葡萄糖代谢产生有益的代谢作用。本研究的目的是探讨白藜芦醇在预防非酒精性脂肪性肝病(NAFLD)中的作用以及在高脂饮食喂养的小鼠中肝脏炎症标志物的表达。

方法和步骤

将18只雄性小鼠分为三组,分别用标准饮食(ST)、高脂饮食(HFD)或高脂饮食加白藜芦醇(HFD + RSV,30 mg/kg/d)喂养60天。评估体重、食物摄入量以及血清总胆固醇、三酰甘油、胰岛素、丙氨酸转氨酶(ALT)和天冬氨酸转氨酶(AST)。分析肝脏组织学。通过定量实时逆转录聚合酶链反应(qRT-PCR)评估ACC、PPAR-γ、ChREBP、SREBP-1c、CPT-1、肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)、NF-κB、白细胞介素1β(IL-1β)和SIRT1的表达。

结果

本研究的主要发现是RSV降低了体脂、总胆固醇、三酰甘油、转氨酶和胰岛素血浆水平。这些结果伴随着肝脏中TNF-α、IL-6和NF-κB mRNA表达的显著降低。肝脏脂肪生成相关基因的分析表明,HFD + RSV小鼠中ACC、PPAR-γ和SREBP-1 mRNA表达被显著抑制。此外,我们观察到HFD + RSV组中SIRT1的表达增加。

结论

我们观察到白藜芦醇治疗改善了脂质代谢,并降低了肥胖诱导饮食小鼠肝脏中的NAFLD和促炎状态。这些数据表明RSV在预防肝脏疾病方面具有重要的临床应用价值。

相似文献

1
Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.白藜芦醇通过减少脂肪生成和炎症来减轻高脂喂养小鼠的肝脂肪变性。
Nutrition. 2014 Jul-Aug;30(7-8):915-9. doi: 10.1016/j.nut.2013.11.016. Epub 2013 Dec 4.
2
Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity.白藜芦醇可预防调节性 T 细胞生成受抑制、氧化应激和炎症,可预防易发生或抵抗高脂肪饮食诱导肥胖的小鼠发生上述情况。
Nutr Res. 2013 Nov;33(11):971-81. doi: 10.1016/j.nutres.2013.07.016. Epub 2013 Aug 27.
3
Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats.白藜芦醇可预防大鼠肝脂肪变性和内质网应激,并调节参与脂质代谢、胰岛素抵抗和炎症的基因表达。
Nutr Res. 2015 Jul;35(7):576-84. doi: 10.1016/j.nutres.2015.05.006. Epub 2015 May 21.
4
(S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.新型异喹啉生物碱(S)YS - 51通过抑制脂肪生成、炎症和凝血来减轻小鼠肥胖相关的非酒精性脂肪性肝病。
Eur J Pharmacol. 2016 Oct 5;788:200-209. doi: 10.1016/j.ejphar.2016.06.040. Epub 2016 Jun 23.
5
Ethanolic extract of seabuckthorn (Hippophae rhamnoides L) prevents high-fat diet-induced obesity in mice through down-regulation of adipogenic and lipogenic gene expression.沙棘( Hippophae rhamnoides L )乙醇提取物通过下调脂肪生成和脂肪生成基因表达来预防高脂饮食诱导的肥胖。
Nutr Res. 2012 Nov;32(11):856-64. doi: 10.1016/j.nutres.2012.09.015.
6
Distinct metabolic effects of resveratrol on lipogenesis markers in mice adipose tissue treated with high-polyunsaturated fat and high-protein diets.白藜芦醇对高多不饱和脂肪和高蛋白饮食处理的小鼠脂肪组织中脂肪生成标志物的独特代谢作用。
Life Sci. 2016 May 15;153:66-73. doi: 10.1016/j.lfs.2016.04.014. Epub 2016 Apr 14.
7
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.虾青素和安卡黄素作为天然 AMPK 激活剂,具有 PPARα 激动剂活性,可下调高脂饮食喂养的 C57BL/6 小鼠的非酒精性脂肪性肝炎。
Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.
8
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.限制蛋氨酸摄入可防止瘦素缺乏型肥胖小鼠的肝脂肪变性进展。
Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.
9
Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease.白藜芦醇在治疗非酒精性脂肪肝病的小鼠模型中调节自噬和 NF-κB 活性。
Food Chem Toxicol. 2014 Jan;63:166-73. doi: 10.1016/j.fct.2013.08.036. Epub 2013 Aug 24.
10
Platycodon grandiflorus Root Extract Attenuates Body Fat Mass, Hepatic Steatosis and Insulin Resistance through the Interplay between the Liver and Adipose Tissue.桔梗根提取物通过肝脏与脂肪组织之间的相互作用减轻体脂、肝脂肪变性和胰岛素抵抗。
Nutrients. 2016 Aug 30;8(9):532. doi: 10.3390/nu8090532.

引用本文的文献

1
Effect of resveratrol on key signaling pathways including SIRT1/AMPK/Smad3/TGF-β and miRNA-141 related to NAFLD in an animal model.白藜芦醇对动物模型中与非酒精性脂肪性肝病相关的关键信号通路(包括SIRT1/AMPK/Smad3/TGF-β和miRNA-141)的影响。
Res Pharm Sci. 2025 Jun 17;20(3):434-444. doi: 10.4103/RPS.RPS_220_24. eCollection 2025 Jun.
2
Understanding the Link Between Sterol Regulatory Element Binding Protein (SREBPs) and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD).了解固醇调节元件结合蛋白(SREBPs)与代谢功能障碍相关脂肪性肝病(MASLD)之间的联系。
Curr Obes Rep. 2025 Apr 14;14(1):36. doi: 10.1007/s13679-025-00626-y.
3
Deciphering the biophysical aspects of the interaction of 3,5,4'-trihydroxy-trans-stilbene with ribonuclease A: spectroscopic and computational studies.
解析3,5,4'-三羟基反式芪与核糖核酸酶A相互作用的生物物理方面:光谱和计算研究
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):5773-5783. doi: 10.1007/s00210-024-03664-w. Epub 2024 Nov 28.
4
SIRT1 and FOXO1 role on MASLD risk: effects of DHA-rich n-3 PUFA supplementation and exercise in aged obese female mice and in post-menopausal overweight/obese women.SIRT1 和 FOXO1 在代谢相关脂肪性肝病风险中的作用:富含二十二碳六烯酸的 n-3 多不饱和脂肪酸补充剂和运动对老年肥胖雌性小鼠和绝经后超重/肥胖女性的影响。
J Physiol Biochem. 2024 Aug;80(3):697-712. doi: 10.1007/s13105-024-01044-9. Epub 2024 Sep 12.
5
Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?白藜芦醇是否能改善代谢相关脂肪性肝病(MASLD)?
Int J Mol Sci. 2024 Mar 27;25(7):3746. doi: 10.3390/ijms25073746.
6
Polyphenols: immunonutrients tipping the balance of immunometabolism in chronic diseases.多酚:免疫营养素在慢性病中改变免疫代谢平衡。
Front Immunol. 2024 Mar 15;15:1360065. doi: 10.3389/fimmu.2024.1360065. eCollection 2024.
7
A Comprehensive Review on Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病综合综述
Cureus. 2023 Dec 8;15(12):e50159. doi: 10.7759/cureus.50159. eCollection 2023 Dec.
8
Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver.SIRT1在非酒精性脂肪性肝病中的生物学作用及相关天然产物
Diabetes Metab Syndr Obes. 2023 Dec 8;16:4043-4064. doi: 10.2147/DMSO.S437865. eCollection 2023.
9
Targeting dysregulated lipid metabolism in the tumor microenvironment.靶向肿瘤微环境中失调的脂质代谢。
Arch Pharm Res. 2023 Dec;46(11-12):855-881. doi: 10.1007/s12272-023-01473-y. Epub 2023 Dec 7.
10
Curative role of natural PPARγ agonist in non-alcoholic fatty liver disease (NAFLD).天然过氧化物酶体增殖物激活受体 γ 激动剂在非酒精性脂肪性肝病(NAFLD)中的治疗作用。
Tissue Barriers. 2024 Jul 2;12(3):2289830. doi: 10.1080/21688370.2023.2289830. Epub 2023 Dec 5.